BioCentury
ARTICLE | Clinical News

SA4503: Phase II started

February 4, 2008 8:00 AM UTC

M's Science began a double-blind, international Phase II trial to compare SA4503 to placebo in 60 patients. The company, which granted rights for the product in certain indications to AGY Therapeutics...